Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glaucomatous Eyes”

40 trials

Showing 20 of 40 results

Not applicableStudy completedNCT02376868
What this trial is testing

Maestro Agreement and Precision Study II

Who this might be right for
Normal Healthy Subjects With No Known Ocular DiseasesGlaucomatous EyesEyes With Retinal Diseases
Topcon Medical Systems, Inc. 101
Post-approval studies (Phase 4)Study completedNCT06437639
What this trial is testing

MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)

Who this might be right for
Primary Open-Angle Glaucoma (POAG)
Pharmasoft 80
Large-scale testing (Phase 3)Study completedNCT03825380
What this trial is testing

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
Ocular HypertensionGlaucoma
Laboratoires Thea 485
Not applicableStudy completedNCT02277119
What this trial is testing

Clinical Study of the Optic Disc Parameters

Who this might be right for
Normal Healthy Subjects With No Known Ocular DiseasesGlaucomatous EyesEyes With Retinal Diseases
Topcon Medical Systems, Inc. 109
Not applicableStudy completedNCT04334473
What this trial is testing

IOP and Ocular Biometrics Changes After Phacoemulsification in Glaucoma Patients and Controls

Who this might be right for
GlaucomaCataract
Mai Nasser Abd Elmohsen 37
Not applicableStudy completedNCT02547740
What this trial is testing

Macular Damage in Early Glaucoma and Progression

Who this might be right for
Glaucoma
Columbia University 260
Testing effectiveness (Phase 2)Study completedNCT06903156
What this trial is testing

Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)

Who this might be right for
Primary Open-Angle Glaucoma (POAG)
Pharmasoft 102
Not applicableStudy completedNCT01849536
What this trial is testing

Corneal Biomechanics and Continuous IOP Monitoring Using Soft Contact Lenses in Glaucomatous Patients

Who this might be right for
Open Angle Glaucoma With a Progressive Visual Field
University Hospital, Bordeaux 30
Not applicableStudy completedNCT02526654
What this trial is testing

Heidelberg Edge Perimetry (HEP) Detecting Glaucomatous Visual Field Defects

Who this might be right for
Glaucoma
Wills Eye 115
Not applicableStudy completedNCT02612571
What this trial is testing

Comparing Rates of Glaucoma in Professional Wind Versus Non-Wind Instrument Players

Who this might be right for
GlaucomaIntraocular PressureOptic Neuropathy
Wills Eye 51
Large-scale testing (Phase 3)Study completedNCT02278614
What this trial is testing

Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients

Who this might be right for
Open Angle GlaucomaOcular Hypertension
Laboratoires Thea 242
Testing effectiveness (Phase 2)Study completedNCT00693485
What this trial is testing

Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy

Who this might be right for
Glaucoma, Open-Angle
Allergan 70
Not applicableStudy completedNCT02863224
What this trial is testing

Advanced Glycation End Products as a Biomarker for Accelerated Ageing

Who this might be right for
Primary Open Angle GlaucomaNormal Tension GlaucomaOcular Hypertension
University of Plymouth 131
Not applicableEnrolling By InvitationNCT05875090
What this trial is testing

Glaucoma Portugal Screening Trial

Who this might be right for
Glaucoma
Centro Hospitalar Universitário Lisboa Norte 6,000
Post-approval studies (Phase 4)Study completedNCT01155219
What this trial is testing

Safety, Efficacy Assessment of Geltim LP® 1 mg/g in Ocular Hypertensive or Glaucomatous Patients.

Who this might be right for
Glaucoma
Laboratoires Thea 150
Not applicableNot Yet RecruitingNCT05747781
What this trial is testing

STReetlab Assessment Tool of Activities Daily Living in Glaucoma Patient

Who this might be right for
Optic Neuropathy
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts 100
Post-approval studies (Phase 4)UnknownNCT05299593
What this trial is testing

24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.

Who this might be right for
Glaucoma, Open-AngleOcular Hypertension
Fondazione G.B. Bietti, IRCCS 43
Not applicableStudy completedNCT01862627
What this trial is testing

Macular Retinoschisis and Detachment Associated With Glaucomatous Optic Neuropathy

Who this might be right for
Macular RetinoschisisMacular DetachmentNormal Tension Glaucoma
Kyorin University 11
Early research (Phase 1)Study completedNCT03901781
What this trial is testing

Study of ST266 Given by Intranasal Delivery in Glaucoma Suspect Subjects

Who this might be right for
Ocular Hypertension
Noveome Biotherapeutics, formerly Stemnion 9
Large-scale testing (Phase 3)Temporarily pausedNCT00382395
What this trial is testing

SOLX Gold Shunt Versus Control Implant: Randomized Trial for Refractory Glaucoma

Who this might be right for
GlaucomaGlaucoma, Open Angle
SOLX, Inc. 180
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation